Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19. 

Biotechnology

Valneva

Thomas Lingelbach

Hanneke Schuitemaker

Vincent Dequenne

Petra Pesendorfer

Franck Grimaud

Dipal Patel

Peter Bühler

Juan Carlos Jaramillo

Frederic Jacotot

The Scientific Advisory Team at Valneva provides expert guidance on the research and development of new prophylactic vaccines. They evaluate scientific data, advise on clinical trials, and help shape the strategic direction of vaccine candidates. The team ensures that Valneva's vaccine programs meet rigorous scientific and regulatory standards, facilitating the successful advancement of vaccines from preclinical stages through to commercialization.

Scientific Advisory Team

Scientific and Clinical Operations

Operations Team

Quality Assurance and Control Team

Scientific Advisory Team

About

Team members

Other teams at Valneva

Scientific and Clinical Operations

Operations Team

Quality Assurance and Control Team